Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells.
Jilishitz I, Quiñones JL, Patel P, Chen G, Pasetsky J, VanInwegen A, Schoninger S, Jogalekar MP, Tsiperson V, Yan L, Wu Y, Gottesman SRS, Somma J, Blain SW. Jilishitz I, et al. Among authors: yan l. Mol Cancer Res. 2021 Nov;19(11):1929-1945. doi: 10.1158/1541-7786.MCR-21-0081. Epub 2021 Aug 26. Mol Cancer Res. 2021. PMID: 34446542
A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.
Shaurova T, Yan L, Su Y, Rich LJ, Vincent-Chong VK, Calkins H, Pokharel S, Petkovich M, Seshadri M, Wu Y, Hershberger PA. Shaurova T, et al. Among authors: yan l. Cancer Commun (Lond). 2023 Apr;43(4):503-507. doi: 10.1002/cac2.12401. Epub 2023 Jan 24. Cancer Commun (Lond). 2023. PMID: 36691995 Free PMC article. No abstract available.
11,757 results
You have reached the last available page of results. Please see the User Guide for more information.